Our Goals
- We provide education, resources, and support to kidney cancer patients and caregivers
- We identify patients’ and researchers’ unmet needs
- We engage and educate policymakers on the urgency of kidney cancer research funding
- We urge Congress to fund kidney cancer research
- We increase CDMRP Kidney Cancer Research Program and NIH funding through advocacy
- We provide direct funding to promising ideas
- We propel collaboration and progress in kidney cancer research (Kidney Cancer Research Summit)
- We grow the community of kidney cancer researchers
- We support the development of new treatments by educating patients on trial access and enrollment
- We identify new unmet needs, set new goals, and keep working
Our Mission
Our mission is to accelerate cures for kidney cancer. We engage in patient advocacy and power research by supporting government and industry research funding, facilitating research collaborations, and offering direct financial support for clinical and laboratory researchers with promising ideas. Together, we can find the cure.
NEWLY DIAGNOSED?
You’re not alone. We’ve put together a Patient Resource Center to help you navigate a new diagnosis and beyond. Learn about kidney cancer, various treatment options, patient education events, and how to live well with cancer.
BUILD A CARE TEAM
Join Our Grassroots Army
What are we advocating for?
Awareness? Funding? Research? Cures?
#ESMO21 : QoL is one of the main pillars that should always be kept in mind in the treatment of patients with mRCC!! @myESMO @OncoAlert @AlbigesL
@kidneycan @KidneyCancer @urotoday
#ESMO21 @myESMO GU proffered session Lively question/answer session & discussion led by @AlbigesL , @brian_rini 👉 maintaining patients QOL , a fundamental goal in oncology, + intermittent ...TKI/dose modification may be used in selected patients with #kidneycancer @OncoAlert
Please take a moment to answer this poll from @SoaresAndrey - @kidneycan @KidneyCancer @KCA_Journal https://t.co/NFE46gAslk
After STAR trial results would you consider to recommend treatment interval strategy for patients receiving TKI in 2L after IO based therapy in 1L? Please RT @montypal @drenriquegrande @tompowles1 @cdanicas @brian_rini @TiansterZhang @ERPlimackMD @motzermd @DrChoueiri @AlbigesL
#ESMO21 @myESMO Keynote-564 trial 👉 adjuvant pembrolizumab significantly delay #kidneycancer disease recurrence without compromising patient reported quality of like + physical function ...@DrChoueiri @OncoAlert @kidneycan @tompowles1
Inspiring mood! Resilience. Flipping the switch. Tackling the next next.
🧡💚
I’m resilient. Spent the morning in meltdown, then flipped the switch.
I had a great time at PT, kicked ass.
Looked at my scans again. It could be worse.
Back in the saddle at work too and ready to figure out the next next for my kidney cancer.
Being presented by Dr. Andy Hahn at #ESMO21, a recent study suggests cytoreductive nephrectomy should be considered in patients with certain types of renal cell carcinoma treated with immune ...checkpoint inhibitors: https://t.co/PEMVPxRHzr. #EndCancer https://t.co/aogP46FtTb
Looking forward to #ESMO21 @myESMO. Check out our poster on cytoreductive nephrectomy in met sarcomatoid and/or rhabdoid RCC who receive ICI. Mentored by @PavlosMsaouel @MDAndersonNews
Can’t think of a more deserving individual! Bringing people together across the globe with the mission to improve cancer outcomes for all patients. @DrChoueiri congrats! https://t.co/XlRxemLcRQ
Dear friends
An Amazing way to start #ESMO21
Our biggest heartfelt CONGRATULATIONS to the Heart & Soul of your @OncoAlert network @DrChoueiri who has just been named a GIANT of #Cancer care @GiantsofCC @GCCAwards
We are SO PROUD & congratulate him on this well deserved award!
From those of us who have known you as a GIANT in this field for years already to those just learning today with the announcement of this award, may I say this is SO well deserved. May you never lose... your drive and passion for improving the lives of your patients, @DrChoueiri! https://t.co/kmpltahXl9
Dear friends
An Amazing way to start #ESMO21
Our biggest heartfelt CONGRATULATIONS to the Heart & Soul of your @OncoAlert network @DrChoueiri who has just been named a GIANT of #Cancer care @GiantsofCC @GCCAwards
We are SO PROUD & congratulate him on this well deserved award!
Latest News
KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Program (CDMRP) or KCRP (Kidney Cancer Research Program). Our work is funded by grassroots donors in the kidney cancer community.
